Outcomes and prognostic factors in initially unresectable hepatocellular carcinoma treated using conversion therapy with lenvatinib and TACE plus PD-1 inhibitors

PurposeTo evaluate the outcomes and prognostic factors for patients using conversion therapy with lenvatinib combined with transcatheter arterial chemoembolization (TACE) plus programmed cell death protein-1 (PD-1) inhibitors (LTP) for initially unresectable hepatocellular carcinoma (iuHCC).MethodsD...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Xingzhi Li, Jie Chen, Xiaobo Wang, Tao Bai, Shaolong Lu, Tao Wei, Zhihong Tang, Chengwen Huang, Bin Zhang, Bowen Liu, Lequn Li, Feixiang Wu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2023-01-01
coleção:	Frontiers in Oncology
Assuntos:	conversion therapy PD-1 inhibitors initially unresectable hepatocellular carcinoma transcatheter arterial chemoembolization lenvatinib
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1110689/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!